# Optimal Intrathecal Morphine Dose for Better Post Cesarean Section Analgesia

> **NCT07560501** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Tribhuvan University Teaching Hospital, Institute Of Medicine.** · enrollment: 180 (estimated)

## Conditions studied

- Post Cesarean Section Pain

## Interventions

- **DRUG:** 0.5% bupivacaine heavy with fentanyl
- **DRUG:** 0.5% bupivacaine heavy with fentanyl plus morphine 50 mcg
- **DRUG:** 0.5% bupivacaine heavy with fentanyl plus morphine100 mcg
- **DRUG:** 0.5% bupivacaine heavy with fentanyl plus morphine 150mcg

## Key facts

- **NCT ID:** NCT07560501
- **Lead sponsor:** Tribhuvan University Teaching Hospital, Institute Of Medicine.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2026-12-28
- **Final completion:** 2026-12-28
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07560501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07560501, "Optimal Intrathecal Morphine Dose for Better Post Cesarean Section Analgesia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07560501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*